| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0967892A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
| 01/05/2000 | EP0801685A4 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 01/05/2000 | EP0758342B1 New peptide active substance and production thereof |
| 01/05/2000 | EP0751959B1 Modified polypeptides with increased biological activity |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0673234B1 Tissue protective and regenerative compositions |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/05/2000 | EP0610445B1 Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier |
| 01/05/2000 | EP0570493B1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 01/05/2000 | DE19829789A1 Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze Acne and inflamed comedones effective preparations containing serine proteases, and one or more calcium salts |
| 01/05/2000 | DE19829709A1 Zubereitungen zum Schutze der Kleinkinderhaut vor Dermatitis ammoniacalis Preparations for the Protection of Infants skin from dermatitis ammoniacalis |
| 01/05/2000 | DE19829014A1 Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV Modified C1-esterase inhibitor to block the infectivity of HIV |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/05/2000 | DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein |
| 01/05/2000 | CN1240479A Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 01/05/2000 | CN1240359A Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 01/05/2000 | CN1240358A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 01/05/2000 | CN1240349A Stable glassy state powder formulations |
| 01/05/2000 | CN1240346A Injectable depot gel composition and method of preparing the composition |
| 01/05/2000 | CN1240345A Sphingomyelinase compositions and use thereof |
| 01/04/2000 | US6011175 Inhibition of farnesyltransferase |
| 01/04/2000 | US6011158 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 01/04/2000 | US6011148 Methods for purifying nucleic acids |
| 01/04/2000 | US6011146 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
| 01/04/2000 | US6011137 Fusion proteins |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
| 01/04/2000 | US6011067 The combination of l-glutathione and selenium that acts as its synergistic co-partner, both incorporated in a suitable topical carrier. |
| 01/04/2000 | US6011055 Administering indomethacin, naproxen, ibuprofen, tenidap and imiquod in a pharmacologically acceptable carrier, excipient or diluent. |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011019 Vasoactive effects and free radical generation by β-amyloid peptides |
| 01/04/2000 | US6011018 Regulated transcription of targeted genes and other biological events |
| 01/04/2000 | US6011015 Angiotensin II for improving fertilization |
| 01/04/2000 | US6011014 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/04/2000 | US6011013 Contraceptive compositions and methods |
| 01/04/2000 | US6011012 Cysteine proteinase inhibitors |
| 01/04/2000 | US6011011 Suspensions of somatotropin and growth hormone releasing factor in low molecular weight polyethylene glycol. |
| 01/04/2000 | US6011010 Cytotoxic and antiviral compound |
| 01/04/2000 | US6011009 Method for determining angiogenesis using scatter factor |
| 01/04/2000 | US6011007 Acylated insulin |
| 01/04/2000 | US6011006 Treating migraine, type ii diabetes, sepsis, inflammation and/or vasomotor disturbances |
| 01/04/2000 | US6011005 Administering an effective amount of a fetuin polypeptide. |
| 01/04/2000 | US6011004 Use of growth factors to treat drug-inducted neuropathy |
| 01/04/2000 | US6011003 Vascular endothelial growth factor (vegf) inhibitors |
| 01/04/2000 | US6011002 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/04/2000 | US6011001 Method of protein therapy by orally administering crosslinked protein crystals |
| 01/04/2000 | US6011000 Hematopoietic protein or a positive hemoglobin modulating agent and either thiophenoxyacetic acid, thiophenoxypropionic acid, thiophenoxybutyric acid, ethyl butyrate, a dihydrocinnamic acid or pharmaceutically acceptable salts |
| 01/04/2000 | US6010906 Antisense modulation of Jun N-terminal kinase kinase-1 expression |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
| 01/04/2000 | US6010884 Recombinant binding proteins and peptides |
| 01/04/2000 | US6010883 Recombinant fusion proteins |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010880 Inhibitors of human plasmin derived from the kunitz domains |
| 01/04/2000 | US6010879 Polynucleotides encoding human mitochondrial chaperone proteins |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010876 Clavanins |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
| 01/04/2000 | US6010864 Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof |
| 01/04/2000 | US6010859 RAB protein |
| 01/04/2000 | US6010854 Autoantibodies to neurotransmitter receptors |
| 01/04/2000 | US6010853 Siva genes, novel genes involved in CD27-mediated apoptosis |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | US6010845 Leukocyte adhesion assay |
| 01/04/2000 | US6010844 Methods of preparing and recovering proteins |
| 01/04/2000 | US6010722 Oral remedy for rheumatoid arthritis and functional food |
| 01/04/2000 | US6010712 Therapeutic use of bFGF to treat conditions involving adhesion of cytotoxic white cells to endothelium |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | US6010699 Administering plasminogen activator |
| 01/04/2000 | US6010694 Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 01/04/2000 | CA2104474C Compositions and methods for topical administration of pharmaceutically active agents |
| 01/04/2000 | CA2093145C Substantially pure interleukin-9 receptor and uses thereof |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA2022848C Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 12/30/1999 | DE19828047A1 New sulfonyl-substituted cyclooctadepsipeptide derivatives useful for prevention and treatment of helminth infection |
| 12/30/1999 | DE19827907A1 Synergistic composition for treating infant or adult respiratory distress syndrome |
| 12/30/1999 | DE19827837A1 Preparation of conjugates for predictive testing, diagnosis, prophylaxis or therapy of immunological sensitization to chemicals |
| 12/30/1999 | CA2276564A1 Modified c1 esterase inhibitor for blocking the infectiousness of hiv |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067644A1 Assay to indicate the presence of non-fertilisable ova |
| 12/29/1999 | WO1999067426A1 Absorptive hypercalciuria locus on human chromosome 1 |
| 12/29/1999 | WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 12/29/1999 | WO1999067403A1 Diacylglycerol o-acyltransferase |
| 12/29/1999 | WO1999067400A1 Tissue-specific and target rna-specific ribozymes |
| 12/29/1999 | WO1999067399A1 HUMAN GLYCOPROTEASE-LIKE PROTEINS AND DNAs ENCODING THESE PROTEINS |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067391A1 Origin of replication and methods of use |